BDXBecton, Dickinson And Co.
BDX
Becton, Dickinson And Co.2,805
Mkt Cap
$75.71BVolume
19,011.0052W High
$184.9452W Low
$127.54PE Ratio
26.62BDX Fundamentals
Price
$162.98Prev Close
$165.05Open
$160.3150D MA
$157.00Beta
0.50Avg. Volume
1.8MEPS (Annual)
$5.82P/B
1.83Rev/Employee
$303,333.33Poll
Earnings Recap
• Reported GAAP EPS of $1.34 up 27.62% YoY • Reported revenue of $5.25B up 1.63% YoY • BD affirms fiscal year 2026 revenue growth guidance as low single-digit plus and low single-digit on a foreign currency-neutral basis, with Adjusted Diluted EPS projected between $12.35 and $12.65 for New BD.
Bullish
BD achieved stronger-than-expected Q1 revenue growth of 1.6% and advanced strategic innovation with FDA clearance for EnCor EnCompass. BD also invested $110M in BD Neopak Glass Prefillable Syringe production.
Bearish
BD's adjusted diluted EPS declined 15.2% in Q1, alongside an 8.3% revenue decrease in the Life Sciences segment and a 2.8% FXN international revenue decline, highlighting profitability and market challenges.